Dynatronics ($DYNT) Director Receives Stock Award as Compensation
DYNATRONICS CORP
Subscribe to track DYNT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Dynatronics ($DYNT) Director Receives Stock Award
Company: DYNATRONICS CORP (DYNT) Form: 4 | Filed: 2025-10-15 Significance: Low
Insider: HOLTZ DAVID B Title: null | Relationship: Director
Transaction: • Type: Grant/Award • Shares: 2,000 • Price: $0.0629 • Value: $125.80 • Owned After: 32,968
Key Insight: A director received a small, routine stock award as compensation for services, as noted in the filing. This is not an open-market purchase.
Market Context: This is a non-market transaction with minimal value, unlikely to impact investor sentiment or stock price. It represents standard corporate governance.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: DYNATRONICS CORP (DYNT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director of Dynatronics Corp received a small stock award valued at approximately $126 as compensation for services. This is a routine, non-market transaction with negligible financial impact.
- Market Impact: Neutral. The transaction is too small in value and is a compensatory grant, not an open-market purchase, indicating it is highly unlikely to influence the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | DYNATRONICS CORP |
| Ticker Symbol | DYNT |
| CIK | 0000720875 |
| Industry | Surgical & Medical Instruments & Apparatus [3841] |
Insider Information
| Field | Value |
|---|---|
| Name | HOLTZ DAVID B |
| CIK | 0001187583 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-15 |
| Transaction Code | A (Grant, award, or other acquisition) |
| Security Type | Common Stock |
| Shares Involved | 2,000 |
| Price Per Share | $0.0629 |
| Total Value | $125.80 |
| Shares Owned After | 32,968 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a grant for services rendered, not a discretionary open-market purchase reflecting insider sentiment. The total value is de minimis and carries no significant signaling power to the market.
Volume & Sentiment
- Expected Volume Impact: Negligible. As a non-market transaction, this filing will not directly impact trading volume.
- Sentiment Indicator: Neutral. This type of filing is a standard part of corporate governance and does not provide a bullish or bearish signal.
Investment Insights
Positive Market Indicators
- Aligns director interests with shareholders through equity ownership, even if the amount is small.
Risk Factors
- The transaction itself presents no risk. It is not an indicator of insider confidence or lack thereof.
Key Takeaways
- Compensation, Not Conviction: The transaction is a routine award for director services, not an investment decision based on the company's future prospects.
- Low Value: The total value of $125.80 is immaterial from a market signaling perspective.
- No Market Impact: This event is unlikely to be a catalyst for any price movement.
Contextual Analysis
Timing Significance
- The filing was made on the same day as the transaction and period of report, indicating timely disclosure. The valuation date mentioned in the footnote (June 30, 2025) suggests this is part of a pre-determined compensation schedule.
Transaction Context
- Footnote 1 clarifies the nature of the transaction: "$0.0629 per share, shares issued as s compensation for services as a Director of the Issuer, valued at the closing price as of June 30, 2025." This confirms it is a non-cash compensation event.
Company Context
- Dynatronics operates in the medical instruments sector. This filing represents a routine corporate action and should be viewed in the context of the company's overall compensation policies for its board of directors.
Risk Assessment
Risk Level: Low
Risk Factors
- There are no significant risks associated with this specific filing.
Market Considerations
- Investors should focus on the company's fundamental performance, industry trends, and substantive insider transactions (i.e., large open-market buys or sells) rather than routine compensation grants like this one.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-15 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
